(81 days)
No
The description focuses on providing access, visualization, and illumination, and mentions basic video processing for display, but there is no mention of AI or ML capabilities for analysis, interpretation, or decision support.
No
The device provides minimally invasive access, visualization, illumination, and magnification of the surgical area; it does not directly treat a condition or disease.
No
The device is primarily an access and visualization tool for minimally invasive spine surgery. While it provides live video images, its stated purpose is to allow surgeons to see the surgical area, not to diagnose a condition.
No
The device description explicitly details hardware components including a sheath, imager, image control box, and cables, which are integral to its function.
Based on the provided information, the Voyant System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is to provide "minimally invasive access, visualization, illumination, and magnification of the surgical area of the spine." This describes a surgical tool used during a procedure to aid the surgeon, not a device used to examine specimens outside the body to diagnose a condition.
- Device Description: The description details a system for accessing and visualizing the surgical site in the spine. It involves a sheath for access and an imager for visualization. This aligns with a surgical instrument, not an IVD.
- Anatomical Site: The device is used on the "spine," which is a part of the patient's body, not a biological specimen.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, tissue, urine, etc.), performing tests on these samples, or providing diagnostic information based on such analysis.
In summary, the Voyant System is a surgical device designed to assist in minimally invasive spine surgery by providing access and visualization. It does not fit the definition of an In Vitro Diagnostic device, which is used to examine specimens outside the body to obtain information for diagnostic purposes.
N/A
Intended Use / Indications for Use
The Voyant System is indicated to provide minimally invasive access, visualization, illumination, and magnification of the surgical area of the spine.
Product codes
HRX
Device Description
The Voyant System is composed of the Voyant Sheath and Voyant Imager, and Accessories which includes an Image Control Box (ICB) and connecting cables. The Voyant Sheath and Voyant Imager are supplied sterile by ethylene oxide (EtO) while the ICB and connecting cables are supplied non-sterile and are The Voyant System is used in minimally invasive spine surgery to provide access and reusable. visualization of the surgical area of the spine.
The Voyant System is a sterile, single-use access and visualization device consisting of a Sheath for access to the spine and an Imager for illumination and visualization of the surgical area. The Sheaths are available in multiple diameters and lengths to accommodate a variety of patient anatomies and spinal surgical procedures. Likewise, the Voyant Imager is available in corresponding diameters to attach to the Voyant Sheath. The Voyant Imager connects to the Image Control Box (ICB) via an HDMI cable and live video image is displayed to a connected external HD monitor in the operating room. The ICB functions to power the Voyant Imager, process video data from the Voyant Imager to display live video image to the connected third-party HD Monitor.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Spine
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical verification testing was performed to demonstrate that the subject Voyant System is substantially equivalent to the predicate device. Testing included design verification testing, software validation, electrical safety and electromagnetic emissions and immunity testing, sterilization testing, and packaging and shelf-life validation testing. The results demonstrate that the subject Voyant System is substantially equivalent to the predicate.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.1100 Arthroscope.
(a)
Identification. An arthroscope is an electrically powered endoscope intended to make visible the interior of a joint. The arthroscope and accessories also is intended to perform surgery within a joint.(b)
Classification. (1) Class II (performance standards).(2) Class I for the following manual arthroscopic instruments: cannulas, currettes, drill guides, forceps, gouges, graspers, knives, obturators, osteotomes, probes, punches, rasps, retractors, rongeurs, suture passers, suture knotpushers, suture punches, switching rods, and trocars. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 888.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
October 2, 2018
Viseon, Inc. Cora Sim Regulatory Affairs Manager 13900 Alton Parkway, Suite 125 Irvine, California 92618
Re: K181885
Trade/Device Name: Voyant System Regulation Number: 21 CFR 888.1100 Regulation Name: Arthroscope Regulatory Class: Class II Product Code: HRX Dated: July 12, 2018 Received: July 13, 2018
Dear Cora Sim:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmr/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4. Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely. Jennifer R. Stevensor For Binita S. Ashar, M.D., M.B.A., F.A.C.S
Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K181885
Device Name Voyant System
Indications for Use (Describe)
The Voyant System is indicated to provide minimally invasive access, visualization, illumination, and magnification of the surgical area of the spine.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
_ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for VISEON INC. The logo features a stylized letter "V" in two shades of blue, with the left side being a lighter teal color and the right side being a darker blue. To the right of the "V" is the company name, "VISEON," in a blue sans-serif font. Below the "ON" in "VISEON" is the word "INC." in a smaller font size.
Voyant System 510(k) Summary - K181885
In accordance with Title 21 of the Code of Federal Regulations, Part 807, and in particular 21 CFR §807.92, the following summary of information is provided:
A. Submitted by:
Cora Sim Regulatory Affairs Manager Viseon, Inc. 13900 Alton Parkway, Suite 125 Irvine, CA 92618 Telephone: (949) 662-3959 ext. 106 Facsimile: (949) 581-4761
Date Prepared: September 10, 2018
B. Device Name:
| Trade or Proprietary Name: | Voyant System |
|---|---|
| Common or Usual Name: | Arthroscope |
| Classification Name: | Arthroscope |
| Device Class: | Class II |
| Classification: | 21 CFR § 888.1100 |
| Product Code: | HRX |
C. Predicate Device:
The subject Voyant System is substantially equivalent to the predicate device, Medtronic METRx System (K002931).
D. Device Description:
The Voyant System is composed of the Voyant Sheath and Voyant Imager, and Accessories which includes an Image Control Box (ICB) and connecting cables. The Voyant Sheath and Voyant Imager are supplied sterile by ethylene oxide (EtO) while the ICB and connecting cables are supplied non-sterile and are The Voyant System is used in minimally invasive spine surgery to provide access and reusable. visualization of the surgical area of the spine.
The Voyant System is a sterile, single-use access and visualization device consisting of a Sheath for access to the spine and an Imager for illumination and visualization of the surgical area. The Sheaths are available in multiple diameters and lengths to accommodate a variety of patient anatomies and spinal surgical procedures. Likewise, the Voyant Imager is available in corresponding diameters to attach to the Voyant Sheath. The Voyant Imager connects to the Image Control Box (ICB) via an HDMI cable and live video image is displayed to a connected external HD monitor in the operating room. The ICB functions to power the Voyant Imager, process video data from the Voyant Imager to display live video image to the connected third-party HD Monitor.
4
Image /page/4/Picture/0 description: The image shows the logo for Viseon Inc. The logo consists of a stylized letter V in two shades of blue, followed by the company name "VISEON" in bold, blue sans-serif letters. Below the company name, in smaller letters, is the abbreviation "INC."
E. Indications for Use:
The Voyant System is indicated to provide minimally invasive access, visualization, and magnification of the surgical area of the spine.
F. Substantial Equivalence:
Documentation that includes design verification testing results and detailed comparison to the predicate device demonstrates that the Voyant System is substantially equivalent to the following 510(k) cleared device:
| Trade Name: | METRx™ System |
|---|---|
| Common Name: | Arthroscope |
| 510(k) Clearance Number: | K002931 |
In addition, the Voyant System designates the following 510(k) cleared reference device:
| Trade Name: | NeedleCam HD™ Visualization System |
|---|---|
| Common Name: | Arthroscope / Endoscope and Accessories |
| 510(k) Clearance Number: | K143705 |
Substantial equivalence is based on intended use, technological characteristics, principles of operation, designs, and on bench testing performed.
The Voyant System subject of this 510(k) and the predicate METRx System have the same intended use. Specifically, the Voyant System and the predicate device are both arthroscopic devices intended to provide access and visualization of the surgical area.
Both the Voyant System and predicate device utilize aluminum alloy tubular retractors to provide access to the surgical area. The subject and predicate devices both utilize a camera component and light source to provide visualization and illumination of the intended surgical area, which is displayed on an external HD monitor. The surgical technique for creating a surgical incision and tissue dilation is the same for both the predicate and subject device. As shown in this submission, the differences in the indications for use, mainly, the Voyant System being indicated for the surgical area of the spine, versus the predicate METRx System being indicated for any area of the body, do not raise new questions of safety and effectiveness as both devices are intended to provide access and visualization of the intended surgical area.
As was established in this submission, the subject Voyant System is substantially equivalent to the predicate METRx System (K002931) previously cleared by the FDA for commercial distribution in the United States. The subject device has been shown to be substantially equivalent and have equivalent technological characteristics to its predicate device through comparison in areas including design, intended use, materials, and function.
5
Image /page/5/Picture/0 description: The image shows the logo for VISEON INC. The logo features a stylized letter "V" in teal and dark blue, followed by the word "VISEON" in dark blue, block letters. Below the word "VISEON" is the word "INC." in smaller, dark blue letters.
G. Performance Data
Non-clinical verification testing was performed to demonstrate that the subject Voyant System is substantially equivalent to the predicate device. Testing included design verification testing, software validation, electrical safety and electromagnetic emissions and immunity testing, sterilization testing, and packaging and shelf-life validation testing. Testing was performed in accordance with the following standards in order to establish equivalence to the predicate device:
| Test/Document Description | Applicable Test Standard |
|---|---|
| Sterilization | ANSI/AAMI/ISO 11135 |
| ANSI/AAMI/ISO 11737-1 | |
| ANSI/AAMI/ISO 11737-2 | |
| Packaging and shelf-life | ISO 11607-1 |
| ASTM F1980-16 | |
| ASTM F88/F88 M-15 | |
| BS EN 868-5 | |
| ASTM F 2096-11 | |
| ASTM D 4169-16 | |
| ISTA Procedure 2A | |
| Electrical Safety | IEC 60601-1 |
| IEC 60601-2-18 | |
| Electromagnetic Emissions and | |
| Immunity | IEC 60601-1-2 |
| Software | IEC 62304 |
| Risk Management | EN ISO 14971 |
| Design Verification Testing | N/A |
The results demonstrate that the subject Voyant System is substantially equivalent to the predicate.
H. Conclusions
The subject Voyant System has been shown to be substantially equivalent to the legally marketed predicate device for its intended use.